(UroToday.com) Radical cystectomy (RC) is known to have significant perioperative complications with rates of readmission approaching 50% in some series. The use of robotic approaches was hoped to decrease the morbidity associated with radical cystectomy. This is supported by retrospective cohort studies. While powered for oncologic outcomes, the RAZOR trial is the largest randomized trial that has assessed perioperative outcomes. In a moderated poster presentation at the American Urologic Association Virtual Annual Meeting, Vivek Venkatramani, MD, and colleagues report on their analysis of postoperative complication rates and evaluated predictors of complications up to 3 months following RC in patients from the RAZOR trial.